Results 221 to 230 of about 44,732 (239)

In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency

Proceedings of the National Academy of Sciences of the United States of America, 2016
Tomohiko Sadaoka, Daniel P Depledge, Labchan Rajbhandari   +2 more
exaly  

Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts

Journal of Medical Virology, 2008
Randall J Cohrs, Satish K Mehta, D Scott Schmid   +2 more
exaly  

Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: A case-control study

Journal of Allergy and Clinical Immunology, 2010
, Helen G Durkin, Rauno Joks
exaly  

Varicella-zoster virus post-exposure management and prophylaxis: A review

Preventive Medicine Reports, 2019
Anne M Lachiewicz
exaly  

Varicella-Zoster Virus

2003
Norberto E. Soto, Stephen E. Straus
openaire   +2 more sources

Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults

Human Vaccines and Immunotherapeutics, 2018
Stephanie Volpe, Roman Chlíbek, Jan Hendrik Richardus   +2 more
exaly  

Varicella-zoster virus: molecular virology and virus–host interactions

Current Opinion in Microbiology, 2001
Ann M Arvin
exaly  

Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group

Human Vaccines and Immunotherapeutics, 2016
Ui Yoon Choi, Dong Ho Huh, Jong-Hyun Kim   +2 more
exaly  

Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child

European Journal of Pediatrics, 2002
Andreas Sauerbrei, Burdach Stefan, Horneff Gerd   +2 more
exaly  

Novel agents for the therapy of varicella-zoster virus infections

Expert Opinion on Investigational Drugs, 2000
Robert Snoeck, Graciela Andrei, Erik De Clercq   +2 more
exaly